“Computational Drug Repurposing of a Ketamine–Methylphenidate Conjugate for Targeting GLIPR1 in Human Glioma: Computational Targeting of GLIPR1 Using a Ketamine–Methylphenidate Conjugate” (2025) Futuristic Biotechnology, 5(4), pp. 67–72. doi:10.54393/fbt.v5i4.220.